Fenofibric acid - TakedaAlternative Names: Fibricor; MPC-028
Latest Information Update: 21 Mar 2016
At a glance
- Originator URL Pharma
- Class Antihyperlipidaemics; Butyric acids; Fibric acid derivatives; Propionates; Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia